Study: VAP Comprehensive Cholesterol Test Improves Outcomes, Reduces Costs by 35% for Managed Care
| NewsRx |
New clinical trial results demonstrated that using the VAP® (Vertical Auto Profile) comprehensive cholesterol test in a disease management program for cardiac patients resulted in better patient care and significant direct medical cost savings (see also Heart Disease).
The study Improved Cardiac Management with a Disease Management Program Incorporating Comprehensive Lipid Profiling, recently published in the online edition of Population Health Management, suggests that the comprehensive VAP Test provides improved risk stratification to enable early intervention with more targeted and aggressive lipid treatment strategies and better disease management than the standard lipid profile.
The two-year, retrospective cohort study reviewed the cases of more than 2,000 patients enrolled in a
"Our research demonstrated that WellMed achieved a positive impact on patient outcomes in its cardiac disease management program by using the comprehensive VAP Cholesterol Test," said Piefer. "The detailed VAP Test was able to identify multiple dyslipidemias in cardiac patients participating in the program. This enabled more targeted therapy for the VAP cases group, which resulted in improved health care and lower costs for enrolled cardiac patients."
Clinicians observed that dyslipidemia leading to cardiovascular disease is due to complex gene-environment interactions, and routine lipid profiles do not detect many of these abnormalities. The standard lipid profile only reports calculated LDL, HDL, triglycerides and total cholesterol, while the VAP Test directly measures 22 separate components of cholesterol, including LDL density, IDL, HDL subclasses, and Lp(a). This added information allows the clinician and the managed care organization to improve risk identification and assessment, and target the correct therapy for best results. In the clinical trial, WellMed researchers used a combination of HDL subclass and LDL density information to guide therapeutic decisions, which resulted in better lowering of LDL [bad cholesterol] and raising of HDL [good cholesterol].
Although further study is recommended, the authors concluded that using the VAP Test during the two-year trial allowed WellMed to detect more cases with dyslipidemia than the standard lipid panel and prescribe more appropriate and effective therapy leading to better outcomes. The authors said the findings suggest significant savings can be achieved when a comprehensive lipid profile is used in conjunction with treatment protocols based on the levels of detailed lipid components.
For information, visit www.Atherotech.com or call 877.901.8510.
| Copyright: | (c) 2012 Obesity, Fitness & Wellness Week via NewsRx.com |
| Wordcount: | 663 |


Advisor News
- SEC settlement would require Tai Lopez, two others, to pay $6.8 million
- The Gen Z money paradox
- NAIFA applauds final SECURE 2.0 regulations
- What will Democrats in Congress do about healthcare and retirement?
- Election results cloud retirement legislation outlook, experts say
More Advisor NewsAnnuity News
- Best’s Market Segment Report: AM Best Maintains Stable Outlook on US Life/Annuity Insurance Segment
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- Boomers want retirement protection, but their actions don’t match their mindset
- NAIC task force to address LTC riders
- ‘It’s really shocking:’ Regulators scrutinize assets backing annuity sellers
More Annuity NewsHealth/Employee Benefits News
- Samantha Wildow: Mercy Health warns thousands of Medical Mutual of Ohio patients may go out-of-network in 2027
- Hooksett, Auburn, Candia, Londonderry schools face steep SchoolCare health insurance hikes
- 'Everybody missed this': Nevada's state worker insurance mismanaged for years, officials say
- Picking Medicare insurance plan is daunting task – Healthful Hints
- November Issue of Best’s Review Ranks US Life Reinsurers and More
More Health/Employee Benefits NewsLife Insurance News
- November Issue of Best’s Review Ranks US Life Reinsurers and More
- Nebraska widow’s big win against life insurer in legal limbo
- New York Life Announces Record $3.1 Billion in Policy Owner Dividends for 2027
- AM Best Affirms Credit Ratings of Massachusetts Mutual Life Insurance Company and Its Subsidiaries
- U-Haul Holding Company to Participate in Deutsche Bank Conference
More Life Insurance News